{"article_title": "Intuitive Surgical Earnings Preview", "article_keywords": ["surgical", "preview", "earnings", "intuitive"], "article_url": "http://www.forbes.com/sites/greatspeculations/2014/10/20/intuitive-surgical-earnings-preview-procedure-volumes-in-focus/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Great Speculations", "og": {"site_name": "Forbes", "description": "When the company announces its third quarter earnings, we expect overall sales to remain under pressure owing to lingering concerns surrounding its da Vinci robotic surgical system and a reduction in the number of robot-assisted surgical procedures. We expect gross margins to decline further in the near term due to higher costs owing to overall lower production and the company\u2019s focus on new products such as the da Vinci Xi and da Vinci Sp (which have slightly lower margins). However, we expect margins to improve in the long run as production volumes increase and its new products gain more acceptance.", "title": "Intuitive Surgical Earnings Preview: Procedure Volumes In Focus", "url": "http://www.forbes.com/sites/greatspeculations/2014/10/20/intuitive-surgical-earnings-preview-procedure-volumes-in-focus/", "image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "updated_time": "2014-10-20T13:47:56-04:00", "type": "article"}, "twitter": {"image": "http://i.forbesimg.com/media/assets/forbes_1200x1200.jpg", "title": "Intuitive Surgical Earnings Preview: Procedure Volumes In Focus", "description": "When the company announces its third quarter earnings, we expect overall sales to remain under pressure owing to lingering concerns surrounding its da Vinci robotic surgical system and a reduction in the number of robot-assisted surgical procedures. We expect gross margins to decline further in the near term due to higher costs owing to overall lower production and the company\u2019s focus on new products such as the da Vinci Xi and da Vinci Sp (which have slightly lower margins). However, we expect margins to improve in the long run as production volumes increase and its new products gain more acceptance.", "card": "summary_large_image", "site": "@forbes"}, "description": "When the company announces its third quarter earnings, we expect overall sales to remain under pressure owing to lingering concerns surrounding its da Vinci robotic surgical system and a reduction in the number of robot-assisted surgical procedures. We expect gross margins to decline further in the near term due to higher costs owing to overall lower production and the company\u2019s focus on new products such as the da Vinci Xi and da Vinci Sp (which have slightly lower margins). However, we expect margins to improve in the long run as production volumes increase and its new products gain more acceptance.", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Investing,Markets,Stocks", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/investing", "section": "Investing", "modified": "2014-10-20", "published": "2014-10-20", "id": "blogAndPostId/blog/post/25-136031"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Investing,Markets,Stocks"}, "article_summary": ""}